Skip to main content
. 2014 Sep 7;2014:685982. doi: 10.1155/2014/685982

Table 4.

Patient reported process characteristics of TB care at the health facilities in Kamuli district, March–May 2012.

Process characteristic Frequency (N = 392) Percentage
Source of information about TB services
 Referred by a health worker 294 75.19
 Recommended by somebody who has ever used 49 12.53
 From the media 40 10.23
 Others 8 2.05
Informed that you would transmit TB to others
 No 52 13.27
 Yes 340 86.73
Informed when you stop spreading TB to others
 No 94 23.98
 Yes 298 76.02
Informed when next to come back for TB services
 No 64 16.33
 Yes 328 83.67
Informed that TB is cured
 No 24 6.14
 Yes 367 93.86
Informed about side effects of TB drugs
 No 55 31.98
 Yes 117 68.02
Aware of all the signs to stop TB medication
 No 150 87.21
 Yes 22 12.79
Informed about sputum follow-up tests at given points
 No 12 6.98
 Yes 160 93.02
Informed about the link between HIV and TB
 No 24 6.12
 Yes 368 93.88
Advised to take an HIV test
 No 25 6.38
 Yes 367 93.62
HW explained to you how to collect the sample
 No 63 16.11
 Yes 328 83.89
HWs explained things in a way you understand
 No 16 4.08
 Yes 376 95.92
You received all the necessary information you need to know
 No 54 13.78
 Yes 338 86.22
Had enough time to discuss problems with HWs
 No 110 28.06
 Yes 282 71.94
Opinion about attitude of staff at the health facility
 Very good 127 32.48
 Good 179 45.78
 Fair 84 21.48
 Poor 1 0.26
Time spent to receive lab results after handing in second sample
 0–2 working days 270 68.88
 3–5 working days 100 25.51
 More than five working days 22 5.61
Treatment observer checking on your daily intake of drugs
 No 23 16.55
 Yes 116 83.45
Waiting time to see the health care worker
 Less than 1 hour 162 41.33
 1 hour to 2 hours 188 47.96
 More than two hours 42 10.71
Waiting time to receive anti-TB drugs
 0-1 day 115 66.86
 2 working days 39 22.67
 3 working days 12 6.98
 5 working days 6 3.49

Note: Only the newly confirmed TB cases and TB cases on treatment were asked whether they had been told about the side effects of TB drugs, and whether they knew all the signs to stop TB medication (severe skin itching, change of eye colour, impaired vision, and severe vomiting), and whether they had been informed about follow up tests of TB at different points during the course of treatment (n = 172).

Note: Only the TB cases on treatment were asked whether they had a treatment observer checking on their daily intake of anti-TB drugs (n = 139).

Note: Only the newly confirmed TB cases and TB cases on treatment were asked how long they waited to receive anti-TB drugs (n = 172).

Note: Waiting time to receive anti-TB drugs was considered from the time of receipt of laboratory results.

Note: Waiting time to see the health care workers was considered from the time a patient reached the facility to seeing the clinician.